These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 7701146)

  • 21. Re-calculating the sample size in internal pilot study designs with control of the type I error rate.
    Kieser M; Friede T
    Stat Med; 2000 Apr; 19(7):901-11. PubMed ID: 10750058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sample size calculations for clinical studies allowing for uncertainty about the variance.
    Julious SA; Owen RJ
    Pharm Stat; 2006; 5(1):29-37. PubMed ID: 17080926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exact test size and power of a Gaussian error linear model for an internal pilot study.
    Coffey CS; Muller KE
    Stat Med; 1999 May; 18(10):1199-214. PubMed ID: 10363340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estimation after blinded sample size reassessment.
    Posch M; Klinglmueller F; König F; Miller F
    Stat Methods Med Res; 2018 Jun; 27(6):1830-1846. PubMed ID: 27697838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estimating the sample size for a pilot randomised trial to minimise the overall trial sample size for the external pilot and main trial for a continuous outcome variable.
    Whitehead AL; Julious SA; Cooper CL; Campbell MJ
    Stat Methods Med Res; 2016 Jun; 25(3):1057-73. PubMed ID: 26092476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sample size recalculation using conditional power.
    Denne JS
    Stat Med; 2001 Sep 15-30; 20(17-18):2645-60. PubMed ID: 11523074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Variance estimation in clinical studies with interim sample size re-estimation.
    Miller F
    Biometrics; 2005 Jun; 61(2):355-61. PubMed ID: 16011681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A framework for prospectively defining progression rules for internal pilot studies monitoring recruitment.
    Hampson LV; Williamson PR; Wilby MJ; Jaki T
    Stat Methods Med Res; 2018 Dec; 27(12):3612-3627. PubMed ID: 28589752
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Calculation of tolerance limits and sample size determination for clinical trials with dichotomous outcomes.
    Zaslavsky BG
    J Biopharm Stat; 2007; 17(3):481-91. PubMed ID: 17479395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Practical guide to sample size calculations: non-inferiority and equivalence trials.
    Flight L; Julious SA
    Pharm Stat; 2016; 15(1):80-9. PubMed ID: 26604186
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Repeated confidence intervals for adaptive group sequential trials.
    Mehta CR; Bauer P; Posch M; Brannath W
    Stat Med; 2007 Dec; 26(30):5422-33. PubMed ID: 17918195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Re-estimating sample size in cluster randomised trials with active recruitment within clusters.
    van Schie S; Moerbeek M
    Stat Med; 2014 Aug; 33(19):3253-68. PubMed ID: 24719285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blinded sample size re-estimation in superiority and noninferiority trials: bias versus variance in variance estimation.
    Friede T; Kieser M
    Pharm Stat; 2013; 12(3):141-6. PubMed ID: 23509095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A hypothesis test of feasibility for external pilot trials assessing recruitment, follow-up, and adherence rates.
    Wilson DT; Brown J; Farrin AJ; Walwyn REA
    Stat Med; 2021 Sep; 40(21):4714-4731. PubMed ID: 34121221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. On efficient two-stage adaptive designs for clinical trials with sample size adjustment.
    Liu Q; Li G; Anderson KM; Lim P
    J Biopharm Stat; 2012; 22(4):617-40. PubMed ID: 22651105
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the statistical power for multiple tests: a case study.
    Yeo A; Qu Y
    Pharm Stat; 2009; 8(1):5-11. PubMed ID: 18381588
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blinded sample size re-estimation in crossover bioequivalence trials.
    Golkowski D; Friede T; Kieser M
    Pharm Stat; 2014; 13(3):157-62. PubMed ID: 24715672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Practical guide to sample size calculations: an introduction.
    Flight L; Julious SA
    Pharm Stat; 2016; 15(1):68-74. PubMed ID: 26585441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Practical guide to sample size calculations: superiority trials.
    Flight L; Julious SA
    Pharm Stat; 2016; 15(1):75-9. PubMed ID: 26585561
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An improved double sampling procedure based on the variance.
    Proschan MA; Wittes J
    Biometrics; 2000 Dec; 56(4):1183-7. PubMed ID: 11129477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.